Xenon Pharmaceuticals Inc. (XENE) stock forecast and price target
Price $40.48 · data as of November 13, 2026
12-month price target
Average target$71.69
Upside / downside+77.1%
Analysts16
ConsensusStrong buy
Low $46.00Average $71.69High $90.00
Gold marker: average target · white marker: today’s price ($40.48)
Analyst ratings
Strong buy 3Buy 14Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-4.53 | −4.0% | $416670 |
| Next fiscal year ends December 31, 2027 | $-4.64 | −2.4% | $24M |
| Next quarter ends December 31, 2026 | $-1.14 | +12.6% | $416670 |
| Quarter after ends December 31, 2026 | $-1.20 | +8.4% | $0 |
Consensus of the analysts covering Xenon Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Xenon Pharmaceuticals stock price target?
The average 12-month target from 16 analysts is $71.69, 77.1% above the current price of $40.48 Targets range from $46.00 to $90.00.
Is Xenon Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 14 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Xenon Pharmaceuticals expected to earn?
Analysts expect EPS of $-4.53 for the fiscal year ending December 31, 2026 and $-4.64 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.